The correlation of these four mPTC groups with clinicopathologic features, including tumor subtype and BRAF V600E status, the characteristics of tumor growth, and the microscopic appearance of the tumor, was analyzed to investigate their possible relevance for risk stratification (Table 2, Figure 4, Table S2a,b). The gene discussed is BRAF; the disease is neoplasm.